An Infectious cDNA Clone of SARS-CoV-2

Xie, Xuping, Muruato, Antonio, Lokugamage, Kumari G., Narayanan, Krishna, Zhang, Xianwen, Zou, Jing, Liu, Jianying, Schindewolf, Craig, Bopp, Nathen E., Aguilar, Patricia V., Plante, Kenneth S., Weaver, Scott C., Makino, Shinji, LeDuc, James W., Menachery, Vineet D., Shi, Pei-Yong·2020·Cell Host & Microbe
DOI 10.1016/j.chom.2020.04.004

Cited by (649)

Items 401–500 of 649

  1. BNT162b2-elicited neutralization of Delta plus, Lambda, Mu, B.1.1.519, and Theta SARS-CoV-2 variants
    Jianying Liu, Yang Liu, Hongjie Xia, Jing Zou, Scott C. Weaver, Kena A. Swanson, Hui Cai, Mark W. Cutler, David Cooper, Alexander Muik et al. · 2022 · npj Vaccines
  2. Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections
    Jing Zou, Xuping Xie, Mingru Liu, Pei‐Yong Shi, Ping Ren · 2022 · mBio
  3. Anthracyclines inhibit SARS-CoV-2 infection
    Zhen Wang, Qinghua Pan, Ling Ma, Jian‐Yuan Zhao, Fiona A. McIntosh, Zhenlong Liu, Shilei Ding, Rongtuan Lin, Shan Cen, Andrés Finzi et al. · 2023 · Virus Research
  4. Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine
    Alberto Grandi, Michele Tomasi, Irfan Ullah, Cinzia Bertelli, Teresa Vanzo, Silvia Accordini, Assunta Gagliardi, Ilaria Zanella, Mattia Benedet, Riccardo Corbellari et al. · 2023 · Vaccines
  5. Ultrafast-UV laser integrating cavity device for inactivation of SARS-CoV-2 and other viruses
    Sharad Ambardar, Mark Howell, Karthick Mayilsamy, Andrew R. McGill, Ryan J. Green, Subhra Mohapatra, Dmitri V. Voronine, Shyam S. Mohapatra · 2022 · Scientific Reports
  6. A DNA-based non-infectious replicon system to study SARS-CoV-2 RNA synthesis
    Xiaolong Feng, Xiaofan Zhang, Shuangying Jiang, Yuanwei Tang, Chao Cheng, Parthasarathy Abinand Krishna, Xiaoting Wang, Junbiao Dai, Jianyang Zeng, Tian Dong Xia et al. · 2022 · Computational and Structural Biotechnology Journal
  7. Reverse Genetics Systems for Emerging and Re-Emerging Swine Coronaviruses and Applications
    Hui Jiang, Ting Wang, Lingbao Kong, Bin Li, Qi Peng · 2023 · Viruses
  8. Modified Vaccinia Ankara Based SARS-CoV-2 Vaccine Expressing Full-Length Spike Induces Strong Neutralizing Antibody Response
    Nanda Kishore Routhu, Sailaja Gangadhara, Narayanaiah Cheedarla, Ayalnesh Shiferaw, Sheikh Abdul Rahman, Anusmita Sahoo, Pei‐Yong Shi, Vineet D. Menachery, Katharine A. Floyd, Stephanie Fischinger et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  9. CCR2-dependent monocyte-derived cells restrict SARS-CoV-2 infection
    Abigail Vanderheiden, Jeronay King Thomas, Allison Soung, Meredith E. Davis-Gardner, Katharine A. Floyd, Fengzhi Jin, David A. Cowan, Kathryn L. Pellegrini, Adrian Creanga, Amarendra Pegu et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  10. Subgenomic SARS-CoV-2 replicon and reporter replicon cell lines enable ultrahigh throughput antiviral screening and mechanistic studies with antivirals, viral mutations or host factors that affect COVID-19 replication
    Shuiyun Lan, Philip R. Tedbury, Yee Tsuey Ong, Raven Shah, Ryan L. Slack, Maria E. Cilento, Huanchun Zhang, Haijuan Du, Nicole Lulkin, Uyen Q. Le et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  11. Engineering SARS-CoV-2 cocktail antibodies into a bispecific format improves neutralizing potency and breadth
    Zhiqiang Ku, Xuping Xie, Jianqing Lin, Peng Gao, Abbas El Sahili, Hang Su, Yang Liu, Xiaohua Ye, Xin Li, Xuejun Fan et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  12. A high throughput antiviral screening platform for alphaviruses based on Semliki Forest virus expressing eGFP reporter gene
    Yu-Jia Shi, Jiaqi Li, Hong-Qing Zhang, Cheng‐Lin Deng, Qin-Xuan Zhu, Bo Zhang, Xiaodan Li · 2023 · Virologica Sinica
  13. Stabilization of RNA G-quadruplexes in the SARS-CoV-2 genome inhibits viral infection via translational suppression
    Maria Razzaq, Ji Ho Han, Subramaniyam Ravichandran, Jae Hyun Kim, Joon‐Yong Bae, Man‐Seong Park, Shrute Kannappan, Woo‐Chang Chung, Jin‐Hyun Ahn, Moon Jung Song et al. · 2023 · Archives of Pharmacal Research
  14. A yeast-based reverse genetics system to generate HCoV-OC43 reporter viruses encoding an eighth subgenomic RNA
    Brett A. Duguay, Trinity H. Tooley, Eric S. Pringle, John R. Rohde, Craig McCormick · 2025 · Journal of Virology
  15. SARS-CoV2 infection triggers inflammatory conditions and astrogliosis-related gene expression in long-term human cortical organoids
    Mathilde Colinet, Ioana Chiver, Antonela Bonafina, Gérald Masset, Daniel Almansa, Emmanuel Di Valentin, Jean‐Claude Twizere, Laurent Nguyen, Ira Espuny-Camacho · 2025 · Stem Cells
  16. Variant mutation G215C in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidation
    Hannah C. Kubinski, Hannah W. Despres, Bryan A. Johnson, Madaline M. Schmidt, Sara A Jaffrani, Allyson H Turner, Conor D. Fanuele, Margaret G. Mills, Kumari G. Lokugamage, Caroline M. Dumas et al. · 2025 · PLoS Biology
  17. Dynamic SARS-CoV-2 emergence algorithm for rationally-designed logical next-generation vaccines
    David P. Maison, Lauren Lei Ching, Sean B. Cleveland, Alanna C. Tseng, Eileen T. Nakano, Cecilia M. Shikuma, Vivek R. Nerurkar · 2022 · Communications Biology
  18. Advances in Molecular Genetics Enabling Studies of Highly Pathogenic RNA Viruses
    Christian Mittelholzer, Thomas Klimkait · 2022 · Viruses
  19. Inactivation of SARS-CoV-2 in clinical exhaled breath condensate samples for metabolomic analysis
    Shuang Hu, Mitchell M. McCartney, Juan Arredondo, Sumathi Sankaran‐Walters, Eva Borras, Richart W. Harper, Michael Schivo, Cristina E. Davis, Nicholas J. Kenyon, Satya Dandekar · 2021 · Journal of Breath Research
  20. Characterization of the Protective Efficacy Against QX Strain of a Recombinant Infectious Bronchitis Virus With H120 Backbone and QX Spike Gene
    Wenlian Weng, Qingyan Liu, Wenxiang Xue, Huan Wang, Shouguo Fang, Yingjie Sun, Lei Tan, Cuiping Song, Xusheng Qiu, Weiwei Liu et al. · 2022 · Frontiers in Microbiology
  21. Construction and evaluation of a self-replicative RNA vaccine against SARS-CoV-2 using yellow fever virus replicon
    Akina Nakamura, Tomohiro Kotaki, Yurie Nagai, Shunta Takazawa, Kenzo Tokunaga, Masanori Kameoka · 2022 · PLoS ONE
  22. CRISPR-based engineering of RNA viruses
    Artem A. Nemudryi, Anna Nemudraia, Joseph E. Nichols, Andrew M. Scherffius, Trevor Zahl, Blake Wiedenheft · 2023 · Science Advances
  23. Laboratory Worker Self-Contamination with Noninfectious SARS-CoV-2 DNA Can Result in False-Positive Reverse Transcriptase PCR-Based Surveillance Testing
    Theresa L. Montgomery, Michelle Paavola, Emily A. Bruce, Jason Botten, Jessica W. Crothers, Dimitry N. Krementsov · 2021 · Journal of Clinical Microbiology
  24. Phylogenetic and Variant Analysis of 1,040 SARS-CoV-2 Genomes
    Eric Christian Rouchka, Julia H. Chariker, Donghoon Chung · 2020 · Preprints.org
  25. Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects
    Madeleine F. Jennewein, Anna J. MacCamy, Nicholas R. Akins, Junli Feng, Leah J. Homad, Nicholas K. Hurlburt, Emily Seydoux, Yu-Hsin Wan, Andrew B. Stuart, Venkata Viswanadh Edara et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  26. Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2-infected cells
    Manon Venet, Margarida Sá Ribeiro, Élodie Décembre, Alicia Bellomo, Garima Joshi, Marine Villard, David Cluet, Magali Perret, Rémi Pescamona, Helena Païdassi et al. · 2021 · medRxiv
  27. Determinants and Mechanisms of the Low Fusogenicity and Endosomal Entry of Omicron Subvariants
    Panke Qu, John Parker Evans, Chaitanya Kurhade, Cong Zeng, Yi-Min Zheng, Kai Y. Xu, Pei‐Yong Shi, Xuping Xie, Shan‐Lu Liu · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  28. Development of robust antiviral assays using relevant apical-out human airway organoids
    Ji‐Hoon Lee, Julia C. LeCher, Eric Parigoris, Noriyuki Shinagawa, Jason Sentosa, Candela Manfredi, Shu Ling Goh, Ramyani De, Sijia Tao, Keivan Zandi et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  29. Modulation of Paracellular Permeability in SARS-CoV-2 Blood-to-Brain Transcytosis
    Taylor E. Martinez, Karthick Mayilsamy, Shyam S. Mohapatra, Subhra Mohapatra · 2024 · Viruses
  30. Development of viral infectious clones and their applications based on yeast and bacterial artificial chromosome platforms
    Yiyi Wu, Shangqing Gao, Guanya Liu, Mengwei Wang, Ruixiao Tan, Baoying Huang, Wenjie Tan · 2025 · Molecular Biomedicine
  31. Convergent evolution in nucleocapsid facilitated SARS-CoV-2 adaptation for human infection
    Kumari G. Lokugamage, Yiyang Zhou, R. Elias Alvarado, Jessica A. Plante, Yani P. Ahearn, Jennifer C. Chen, Leah K. Estes, William M. Meyers, Jakob Nilsson, Andrew L. Routh et al. · 2025 · Journal of Virology
  32. Nanobody against SARS-CoV-2 non-structural protein Nsp9 inhibits viral replication in human airway epithelia
    Tomáš Venit, Jérémy Blavier, Sibusiso B. Maseko, Sam Shu, Lília Espada, Christopher Breunig, Hans‐Peter Holthoff, Sabrina C. Desbordes, Martin J. Lohse, Gennaro Esposito et al. · 2024 · Molecular Therapy — Nucleic Acids
  33. Hamster organotypic kidney culture model of early-stage SARS-CoV-2 infection highlights a two-step renal susceptibility
    Sophie R Shyfrin, Marion Ferren, Laure Perrin‐Cocon, Maxime Espi, Xavier Charmetant, Manon Brailly, Didier Décimo, Mathieu Iampietro, Lola Canus, Branka Horvat et al. · 2022 · Journal of Tissue Engineering
  34. SARS-CoV-2 Induces Epithelial-Enteric Neuronal Crosstalk Stimulating VIP Release
    Arun Balasubramaniam, Philip R. Tedbury, Simon Musyoka Mwangi, Yunshan Liu, Ge Li, Didier Merlin, Adam D. Gracz, Peijian He, Stefan G. Sarafianos, Shanthi Srinivasan · 2023 · Biomolecules
  35. Identification of a novel inhibitor of SARS‐CoV ‐2 main protease: an in silico , biochemical, and cell‐based approach
    Aditya Trivedi, Vandana Kardam, Krishna Kishore Inampudi, Sudhanshu Vrati, Dharmender Gupta, Aekagra Singh, Sarala Rani Kayampeta, Mohan Babu Appaiahgari, Deepak Sehgal · 2023 · FEBS Journal
  36. Atuação do farmacêutico clínico e comunitário frente a pandemia da COVID-19
    Lucélia Maria Carneiro da Silva, Jeorgio Leão Araújo · 2020 · Research Society and Development
  37. Profile of SARS-CoV-2
    Franz Xaver Heinz, Karin Stiasny · 2020 · Wiener klinische Wochenschrift
  38. Rescue of Infectious Sindbis Virus by Yeast Spheroplast-Mammalian Cell Fusion
    Lin Ding, David Brown, John I. Glass · 2021 · Viruses
  39. Detection and classification of SARS‐CoV‐2 using high‐resolution melting analysis
    Li‐Ying Sun, Leshan Xiu, Chi Zhang, Yan Xiao, Yamei Li, Lulu Zhang, Lili Ren, Junping Peng · 2022 · Microbial Biotechnology
  40. Distinct neutralizing kinetics and magnitudes elicited by different SARS-CoV-2 variant spikes
    Yang Liu, Jianying Liu, Jing Zou, Ping Ren, Scott C. Weaver, Xuping Xie, Pei‐Yong Shi · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  41. Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication
    Zemin Yang, Bryan A. Johnson, Victoria Meliopoulos, Xiaohui Ju, Peipei Zhang, Michael P. Hughes, Jinjun Wu, Kaitlin P. Koreski, Ti‐Cheng Chang, Gang Wu et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  42. Development of SARS-CoV-2 as a viral vector: A novel intranasal bivalent vaccine for SARS-CoV-2 and RSV
    Jiayu Xu, Michelle Chamblee, Fei Jiang, Mahesh KC, Cheng Chih Hsu, Ilada Thongpan, Phylip Chen, Yuexiu Zhang, Chun-Ta Chiu, Mohamed M. Shamseldin et al. · 2025 · Science Advances
  43. Functional and structural basis of Omicron BA.3.2.1 spike
    Yan Wang, Yanping Hu, Zhenhang Chen, Jing Zou, Ke Zhang, Ping Ren, Pei‐Yong Shi, Bo Liang, Xuping Xie · 2026 · Cell Reports
  44. Progress of research on coronaviruses and toroviruses in large domestic animals using reverse genetics systems
    Makoto Ujike, Tohru Suzuki · 2024 · The Veterinary Journal
  45. Insights into the Pathogenesis and Development of Recombinant Japanese Encephalitis Virus Genotype 3 as a Vaccine
    Jae‐Yeon Park, Hye‐Mi Lee, Sung‐Hoon Jun, Wataru Kamitani, Onnuri Kim, Hyun‐Jin Shin · 2024 · Vaccines
  46. Insights into SARS-CoV-2, the Coronavirus Underlying COVID-19: Recent Genomic Data and the Development of Reverse Genetics Systems
    Severino Jefferson Ribeiro da Silva, Renata Pessôa Germano Mendes, Caroline Targino Alves da Silva, Alessio Lorusso, Alain Kohl, Lindomar Pena · 2020 · Journal of General Virology
  47. Antibody Responses to SARS-CoV-2 Following an Outbreak Among Marine Recruits With Asymptomatic or Mild Infection
    Irene Ramos, Carl W. Goforth, Alessandra Soares Schanoski, Dawn L. Weir, Emily C Samuels, Shreshta Phogat, Michelle Meyer, Kai Huang, Colette A. Pietzsch, Yongchao Ge et al. · 2021 · Frontiers in Immunology
  48. Longitudinal Analysis of Biologic Correlates of COVID-19 Resolution: Case Report
    Natalie Bruiners, Valentina Guerrini, Rahul Ukey, Ryan J. Dikdan, Jason H. Yang, Pankaj Kumar Mishra, Alberta Onyuka, Deborah Handler, Joshua A Vieth, Mary O. Carayannopoulos et al. · 2022 · Frontiers in Medicine
  49. Infecting kidney organoids with a cDNA reporter clone of SARS-CoV-2
    Hyunjae Chung, Maxwell P. Bui-Marinos, Waleed M Rahmani, Jennifer A. Corcoran, Justin Chun · 2022 · STAR Protocols
  50. Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic Infection
    Sindhu Vangeti, Sivakumar Periasamy, Peifang Sun, Corey A. Balinsky, Avinash S. Mahajan, Natalia A. Kuzmina, Alessandra Soares Schanoski, Elizabeth S. Cooper, Charmagne G. Beckett, Jan Marayag et al. · 2022 · Microbiology Spectrum
  51. Antibody Binding and Neutralization of Live SARS-CoV-2 Variants Including BA.4/5 Following Booster Vaccination of Patients with B-cell Malignancies
    Andrés Chang, Akil Akhtar, Lilin Lai, Victor Manuel Orellana-Noia, Susanne L. Linderman, Ashley A. McCook‐Veal, Jeffrey M. Switchenko, Manpreet Saini, Rajesh M. Valanparambil, Kristie A. Blum et al. · 2022 · Cancer Research Communications
  52. Calpain-2 mediates SARS-CoV-2 entry via regulating ACE2 levels
    Qiru Zeng, Avan Antia, Luis Alberto Casorla-Perez, Maritza Puray‐Chavez, Sebla B. Kutluay, Matthew A. Ciorba, Siyuan Ding · 2024 · mBio
  53. Local Complement Contributes to Pathogenic Activation of Lung Endothelial Cells in SARS-CoV-2 Infection
    Hui Zhang, Evgenia V. Gerasimovskaya, Mary K. McCarthy, Nicholas A. May, Ram Raj Prasad, Suzette R. Riddle, B.A. McKeon, Sushil Kumar, Min Li, Cheng‐Jun Hu et al. · 2023 · American Journal of Respiratory Cell and Molecular Biology
  54. Rapid, dose-dependent and efficient inactivation of surface dried SARS-CoV-2 by 254 nm UV-C irradiation
    Natalia Ruetalo, Ramona Businger, Michael Schindler · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  55. Broad-spectrum antiviral activity of 3D8, a nucleic acid-hydrolyzing single chain variable fragment (scFv), targeting SARS-CoV-2 and multiple coronaviruses in vitro
    Gunsup Lee, Shailesh Budhathoki, Geum-Young Lee, Kwang-ji Oh, Yeon Kyoung Ham, Young Jun Kim, Ye Rin Lim, Phuong Thi Hoang, Yongjun Lee, Seok-Won Lim et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  56. SARS-CoV-2 Envelope protein (E) binds and activates TLR2: A novel target for COVID-19 interventions
    Rémi Planès, Jean-Baptiste Bert, Sofiane Tairi, Lbachir BenMohamed, Elmostafa Bahraoui · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  57. Development of the coronavirus reverse genetic system: Core technology for pathogenesis mechanisms research and vaccine/drug development
    Yue Zhang, Ruifeng Hou, Zhanyong Wei, Jin Yuan, Shaopo Zu · 2025 · Virulence
  58. Early innate immune response and evolution of a SARS-CoV-2 furin cleavage site inactive variant in bat cells
    Kaushal Baid, Sauhard Shrivastava, Jessica Luc, Daniel J. Richard, Jennifer A. Aguiar, Yoan J. Machado, Sophie‐Marie Aicher, Kimberley C. Siwak, Emmanuelle V. LeBlanc, Zahed Khatooni et al. · 2025 · Cell Reports
  59. SARS-CoV-2 Nsp2 recruits GIGYF2 near viral replication sites and supports viral protein production
    Jimi Kim, Youngran Park, Doil Yoon, Sunghan Lee, Haedong Kim, Ka-Yun Ban, Ji-Hye Yang, Da-Eun Choi, Jeesoo Kim, Jong‐Seo Kim et al. · 2025 · Nucleic Acids Research
  60. Discontinuous template switching generates coronavirus subgenomic RNAs from the 3ʹ viral genome end by 5ʹ to 3ʹ transcription
    Ayslan Castro Brant, Zhe Hu, Angelika Zelma Chen, Vladimır Majerčiak, Jonathan Wilson Yewdell, Zhi‐Ming Zheng · 2025 · Journal of Virology
  61. Membrane Perturbations and Assay Interferences by Ivermectin Explain Its In Vitro SARS-CoV-2 Antiviral Activities and Lack of Translatability
    Richard T. Eastman, Radda Rusinova, Karl F. Herold, Xi-Ping Huang, Ty C. Voss, Alex D. White, Hugh C. Hemmings, Olaf Sparre Andersen, Jayme L. Dahlin · 2025 · Journal of Medicinal Chemistry
  62. Bioluminescent and Fluorescent Reporter-Expressing Recombinant SARS-CoV-2
    Desarey Morales Vasquez, Kevin Chiem, Chengjin Ye, Luis Martínez‐Sobrido · 2022 · Methods in molecular biology
  63. An in vitro workflow to create and modify infectious clones using replication cycle reaction
    Jeffrey M. Marano, Chelsea Cereghino, Carla V. Finkielstein, James Weger‐Lucarelli · 2023 · Virology
  64. An Integrated Research–Clinical BSL-2 Platform for a Live SARS-CoV-2 Neutralization Assay
    Jing Zou, Chaitanya Kurhade, Hope C. Chang, Yanping Hu, Jose A. Meza, David Beaver, Ky Trinh, Joseph Omlid, Bassem Elghetany, Ragini Desai et al. · 2023 · Viruses
  65. Pseudotyping Improves the Yield of Functional SARS-CoV-2 Virus-like Particles (VLPs) as Tools for Vaccine and Therapeutic Development
    Andrew J. Zak, Trang Hoang, Christine M. Yee, Syed Monem Rizvi, Ponnandy Prabhu, Fei Wen · 2023 · International Journal of Molecular Sciences
  66. Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS‐CoV ‐2 infection and COVID ‐19 disease severity
    Philip R. Tedbury, Candela Manfredi, Frauke C. Degenhardt, Joseph Conway, Michael C. Horwath, Courtney McCracken, Adam J. Sorscher, Sandy Moreau, Christine Wright, Carolina Edwards et al. · 2023 · The FASEB Journal
  67. BA.5 bivalent booster vaccination enhances neutralization of XBB.1.5, XBB.1.16 and XBB.1.9 variants in patients with lung cancer
    Rajesh M. Valanparambil, Lilin Lai, Margaret A. Johns, Meredith E. Davis-Gardner, Susanne L. Linderman, Tarrant McPherson, Andrés Chang, Akil Akhtar, Estefany Lucia Bocangel Gamarra, Hayley Matia et al. · 2023 · npj Vaccines
  68. Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platform
    Enja Tatjana Kipfer, David Hauser, Martin Joseph Lett, Fabian Otte, Lorena Urda, Yuepeng Zhang, Christopher M. R. Lang, Mohamed Chami, Christian Mittelholzer, Thomas Klimkait · 2023 · eLife
  69. Persistence of an Infectious Form of SARS-CoV-2 After Protease Inhibitor Treatment of Permissive Cells In Vitro
    Manoj S. Nair, Maria I. Luck, Yaoxing Huang, Yosef Sabo, David D. Ho · 2024 · The Journal of Infectious Diseases
  70. A Comprehensive Review on COVID-19: Emphasis on Current Vaccination and Nanotechnology Aspects
    Hitesh Kumar Dewangan, Akriti Rai, Kamal Shah, Rajiv Sharma · 2022 · Recent Patents on Nanotechnology
  71. Novel ACE2 fusion protein with adapting activity against SARS-CoV-2 variants in vitro
    Latifa Zekri, Natalia Ruétalo, Mary Christie, Carolin Walker, Timo Manz, Hans‐Georg Rammensee, Helmut Rainer Salih, Michael Schindler, Gundram Jung · 2023 · Frontiers in Immunology
  72. SARS-CoV-2 ORF8 encoded protein contains a histone mimic, disrupts chromatin regulation, and enhances replication
    John Kee, Samuel Thudium, David M. Renner, Karl M. Glastad, Katherine C. Palozola, Zhen Zhang, Yize Li, Joseph Cesare, Yemin Lan, Rachel Truitt et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  73. Nucleocapsid 203 mutations enhance SARS-CoV-2 immune evasion
    Xiaoyuan Lin, Weiwei Xue, Yueping Zhang, Beibei Fu, Jakob Trimpert, Na Xing, Dušan Kunec, Wanyan Tang, Yang Xiao, Kaiwen Meng et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  74. Durable protection against SARS-CoV-2 Omicron induced by an adjuvanted subunit vaccine
    Prabhu S. Arunachalam, Yupeng Feng, Usama Ashraf, Mengyun Hu, Venkata Viswanadh Edara, Veronika I. Zarnitsyna, Pyone P. Aye, Nadia Golden, Kristyn Moore Green, Breanna Threeton et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  75. Structural and functional characteristics of SARS-CoV-2 Omicron subvariant BA.2 spike
    Jun Zhang, Weichun Tang, Hailong Gao, Christy L. Lavine, Wei Shi, Hanqin Peng, Haisun Zhu, Krishna Anand, Matina Kosikova, Hyung Joon Kwon et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  76. Metabolic Modeling Elucidates Phenformin and Atpenin A5 as Broad-Spectrum Antiviral Drugs
    Alina Renz, Mirjam Hohner, Maximilian Breitenbach, Jonathan Josephs‐Spaulding, Johanna Dürrwald, Lena Best, Raphaël Jami, Γεώργιος Μαρίνος, Filipe Cabreiro, Andreas Dräger et al. · 2022 · Preprints.org
  77. Bivalent mRNA vaccine improves antibody-mediated neutralization of many SARS-CoV-2 Omicron lineage variants
    Nannan Jiang, Li Wang, Masato Hatta, Chenchen Feng, Michael Currier, Xudong Lin, Jaber Hossain, Dan Cui, Brian R. Mann, Nicholas A. Kovacs et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  78. Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine
    Alberto Grandi, Michele Tomasi, Irfan Ullah, Cinzia Bertelli, Teresa Vanzo, Silvia Accordini, Assunta Gagliardi, Ilaria Zanella, Mattia Benedet, Riccardo Corbellari et al. · 2023 · Research Square
  79. Recapitulation of the Powassan virus life cycle in cell culture
    Jingwei Song, Jia-Yao Hong, Chen Yang, Yu Zhang, Zhuoyang Li, P. F. He, Qiang Ding · 2024 · mBio
  80. Rapid Generation of Reverse Genetics Systems for Coronavirus Research and High‐Throughput Antiviral Screening Using Gibson DNA Assembly
    Xinrong Zhou, Hongchao Liu, Sidi Yang, Xiaoran Dong, Cailing Xie, Weixin Ou, Jinwei Chen, Zixiao Yang, Yuzhen Ye, Konstantin I. Ivanov et al. · 2025 · Journal of Medical Virology
  81. Generation and characterization of infectious clones of chikungunya virus from an Indian strain as a resource towards chikungunya vaccine research
    Garvita Mathur, Shakuntala Mahilkar, Sujatha Sunil · 2025 · Virus Research
  82. Attenuating RNA Viruses with Expanded Genetic Codes to Evoke Adjustable Immune Response in PylRS-tRNACUAPyl Transgenic Mice
    Zhetao Zheng, Yu Wang, Xuesheng Wu, Haoran Zhang, Hongmin Chen, Haishuang Lin, Yuxuan Shen, Qing Xia · 2023 · Vaccines
  83. Preclinical Evaluation and Pilot Clinical Study of 18F-Labeled Inhibitor Peptide for Noninvasive Positron Emission Tomography Mapping of Angiotensin Converting Enzyme 2
    Jin Ding, Qian Zhang, Jinquan Jiang, Nina Zhou, Ziyu Yu, Zilei Wang, Xiangxi Meng, Lasya P. Daggumati, Teli Liu, Feng Wang et al. · 2024 · ACS Pharmacology & Translational Science
  84. Dynamics of cytokine and antibody responses in community versus hospital SARS-CoV-2 infections
    Tulika Singh, Andrew N. Macintyre, Thomas W. Burke, Jack G. Anderson, Elizabeth Petzold, Erica L. Stover, Matthew J. French, Thomas H. Oguin, Todd DeMarco, Micah T. McClain et al. · 2024 · Frontiers in Immunology
  85. Determination of resilience of a panel of broadly neutralizing mAbs to emerging variants of SARS-CoV-2 generated using reverse genetics
    Madeeha Afzal, Diana Melnyk, Thomas Courty, Lisa M. Schimanski, Michelle L. Hill, Stuart J. D. Neil, Tiong Kit Tan, William James · 2025 · iScience
  86. An Overview on Lambda, Epsilon, Kappa, Iota and Zeta Variants of Covid-19 and its Probability to Merge with Delta & Delta Plus, why it is a Concern
    2021 · Biointerface Research in Applied Chemistry
  87. Delta Variant of Covid-19 Study, and Why it is a Concern: An Overview
    2021 · Biointerface Research in Applied Chemistry
  88. A new tool to probe SARS-CoV-2 variants
    Bryan A. Johnson, Vineet D. Menachery · 2021 · Science
  89. Tracking Co-Occurrence of N501Y, P681R, and Other Key Mutations in SARS-CoV-2 Spike for Surveillance
    Carol M. Lee, Shruthi Mangalaganesh, Laurence O.W. Wilson, Michael J. Kuiper, Trevor W. Drew, Seshadri S. Vasan · 2022 · Zoonotic Diseases
  90. Oral Epithelial Cells Expressing Low or Undetectable Levels of Human Angiotensin-Converting Enzyme 2 Are Susceptible to SARS-CoV-2 Virus Infection In Vitro
    Laith Ebraham, Chuan Xu, Annie R. Wang, Cyril Hernandez, Nicholas Siclari, Divino Rajah, Lewins Walter, Salvatore A. E. Marras, Sanjay Tyagi, Daniel H. Fine et al. · 2023 · Pathogens
  91. Identification of DAXX As A Restriction Factor Of SARS-CoV-2 Through A CRISPR/Cas9 Screen
    Alice Mac Kain, Ghizlane Maarifi, Sophie‐Marie Aicher, Nathalie Jane Arhel, Artem Baidaliuk, Sandie Munier, Flora Donati, Thomas Vallet, Quang Dinh Tran, Alexandra Hardy et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  92. Visualization of SARS-CoV-2 infection dynamic
    Chengjin Ye, Kevin Chiem, Jun‐Gyu Park, Jesus A. Silvas, Desarey Morales Vasquez, Jordi Bertran Torrelles, James J. Kobie, Mark R. Walter, Juan Carlos de la Torre, Luis Martínez‐Sobrido · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  93. Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses Against the SARS-CoV-2 Omicron Variant in Adolescents and Adults
    Sneh Lata Gupta, Grace E. Mantus, Kelly E. Manning, Madison Leigh Ellis, Mit Patel, Caroline Rose Ciric, Austin Lu, Jackson S. Turner, Jane A. O’Halloran, Rachael M. Presti et al. · 2022 · SSRN Electronic Journal
  94. Identification and characterization of an immunodominant SARS-CoV-2-specific CD8 T cell response
    Anastasia Gangaev, Steven L. C. Ketelaars, Olga I. Isaeva, Sanne Patiwael, Anna Dopler, Kelly Hoefakker, Sara De Biasi, Lara Gibellini, Cristina Mussini, Giovanni Guaraldi et al. · 2020
  95. Nonspecific membrane bilayer perturbations by ivermectin underlie SARS-CoV-2 in vitro activity
    Richard T. Eastman, Radda Rusinova, Karl F. Herold, Xi‐Ping Huang, Patricia K. Dranchak, Ty C. Voss, Sandeep Rana, Jonathan H. Shrimp, Alex D. White, Hugh C. Hemmings et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  96. SARS-CoV-2 antibody–dependent enhancement of infection depends on antibody binding to both ACE2 and Fc receptors
    Natalia A. Kuzmina, Sivakumar Periasamy, Kritika Kedarinath, Keziah R. Hernandez, Caroline G. Atyeo, S. Moses Dennison, Kan Li, Daniel Bedinger, Sharon L. Schendel, Georgia D. Tomaras et al. · 2026 · JCI Insight
  97. Combined mutations in nonstructural protein 14, envelope, and membrane proteins mitigate the neuropathogenicity of SARS-CoV-2 Omicron BA.1 in K18-hACE2 mice
    Kotou Sangare, Shufeng Liu, Prabhuanand Selvaraj, Charles B. Stauft, Matthew F. Starost, Tony T. Wang · 2024 · mSphere
  98. Immune Profiling to Determine Early Disease Trajectories Associated With Coronavirus Disease 2019 Mortality Rate: A Substudy from the ACTT-1 Trial
    Joshua M. Thiede, Abigail R. Gress, Samuel D Libby, Christine E. Ronayne, William E. Matchett, Brooke Noren, Joanne L. Billings, Vineet D. Menachery, Ryan Andrew Langlois, Susan Kline et al. · 2021 · The Journal of Infectious Diseases
  99. Genomic analysis of SARS-CoV-2 variants of concern circulating in Hawai’i to facilitate public-health policies
    David P. Maison, Sean B. Cleveland, Vivek R. Nerurkar · 2022 · PLoS ONE
  100. Pharmacological modulators of epithelial immunity uncovered by synthetic genetic tracing of SARS-CoV-2 infection responses
    Ben Jiang, Matthias Jürgen Schmitt, Ulfert Rand, Yuliia Dramaretska, Melanie Großmann, Michela Serresi, Luka Čičin‐Šain, Gaetano Gargiulo · 2023 · Science Advances